Sort by
Refine Your Search
-
distinction for three consecutive periods (2014-2018 and 2018-2022 and 2023-2026). ICN2 comprises 19 Research Groups, 7 Technical Development and Support Units and Facilities, and 2 Research Platforms, covering
-
, and to develop therapeutic avenues. The group is particularly interested in understanding how genomic information is used to direct cell-specific gene expression, and to pinpoint gene regulatory defects
-
candidates will be interviewed by Dr Amelie Baud and at least one other Group Leader. Meetings will be organised with team members as well. Offer Letter: Once the successful candidate is identified the People
Searches related to holonomy group
Enter an email to receive alerts for holonomy-group positions